Physician profile
Melissa Y Macias
NPI 1710044383
$529,221.51
in general payments reported to CMS, 2019-2025
10 companies · $136K in 2025
The $136K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $26K · 2021: $55K · 2022: $68K · 2023: $102K · 2024: $114K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $340K · Consulting Fee: $10K · Travel and Lodging: $2,097 · Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $339,840.39 |
| Consulting Fee | $10,125.00 |
| Travel and Lodging | $2,097.44 |
| Food and Beverage | $188.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $528,864.04 | 2019-2025 | Identiti, Invictus Open, Other - Miscellaneous |
| Baxter Healthcare | $87.28 | 2019-2023 | Floseal |
| Seaspine Orthopedics Corporation | $60.20 | 2019 | |
| Medtronic USA, INC. | $58.02 | 2019-2020 | |
| Abbvie INC. | $44.61 | 2023 | |
| Brainlab, INC. | $35.62 | 2019 | |
| Depuy Synthes Sales INC. | $28.77 | 2023 | Na |
| Avanos Medical | $16.63 | 2019 | |
| Lilly USA, LLC | $15.11 | 2019 | |
| Abbott Laboratories | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Macias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.